Influence of Mild Therapeutic Hypothermia on Leukocyte Count
Terminated
- Conditions
- Ventricular Fibrillation
- Registration Number
- NCT00520520
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
Mild therapeutic hypothermia is indicated in patients surviving out-of-hospital cardiac arrest due to ventricular fibrillation. Potential immunologic responses are unknown.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Survivors of cardiac arrest due to VF
- Age 18-90
Exclusion Criteria
- Suspected / proven pregnancy
- Immunodeficiency
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link mild therapeutic hypothermia to leukocyte count modulation in post-cardiac arrest patients?
How does mild therapeutic hypothermia compare to standard-of-care in immune response modulation after ventricular fibrillation cardiac arrest?
Which biomarkers correlate with leukocyte count changes during mild therapeutic hypothermia in OHCA survivors?
What are the potential adverse events associated with mild therapeutic hypothermia in ventricular fibrillation patients and how are they managed?
Are there combination therapies or alternative approaches to mild therapeutic hypothermia for post-cardiac arrest immunomodulation?
Trial Locations
- Locations (1)
Charite University Hospital
🇩🇪Berlin, Germany
Charite University Hospital🇩🇪Berlin, Germany